These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15715968)

  • 41. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
    Kimura Y; Sumiyoshi M; Baba K
    Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.
    Rahimi N
    Exp Eye Res; 2006 Nov; 83(5):1005-16. PubMed ID: 16713597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1.
    Lin CM; Chang H; Chen YH; Li SY; Wu IH; Chiu JH
    Int Immunopharmacol; 2006 Nov; 6(11):1690-8. PubMed ID: 16979123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
    Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
    Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
    Lacal PM; Ruffini F; Pagani E; D'Atri S
    Int J Oncol; 2005 Dec; 27(6):1625-32. PubMed ID: 16273219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships.
    Boyer SJ
    Curr Top Med Chem; 2002 Sep; 2(9):973-1000. PubMed ID: 12171566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of active recombinant catalytic domain of human ErbB-2 tyrosine kinase, and suppression of activity by a naturally derived inhibitor, ZH-4B.
    Guo XN; Zhong L; Zhang XH; Zhao WM; Zhang XW; Lin LP; Ding J
    Biochim Biophys Acta; 2004 Aug; 1673(3):186-93. PubMed ID: 15279890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of 1,3-Diaryl-pyridones as Potent VEGFR-2 Inhibitors: Design, Synthesis, and Biological Evaluation.
    Yan W; Huang Z; Wang Z; Cao S; Tong L; Zhang T; Wang C; Zhou L; Ding J; Luo C; Zhou J; Xie H; Duan W
    Chem Biol Drug Des; 2016 May; 87(5):694-703. PubMed ID: 26669707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study.
    Stewart M; Turley H; Cook N; Pezzella F; Pillai G; Ogilvie D; Cartlidge S; Paterson D; Copley C; Kendrew J; Barnes C; Harris AL; Gatter KC
    Histopathology; 2003 Jul; 43(1):33-9. PubMed ID: 12823710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VEGFR-2 conformational switch in response to ligand binding.
    Sarabipour S; Ballmer-Hofer K; Hristova K
    Elife; 2016 Apr; 5():e13876. PubMed ID: 27052508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovering small molecule ligands of vascular endothelial growth factor that block VEGF-KDR binding using label-free microarray-based assays.
    Landry JP; Fei Y; Zhu X; Ke Y; Yu G; Lee P
    Assay Drug Dev Technol; 2013 Jun; 11(5):326-32. PubMed ID: 23772553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Property-based design of KDR kinase inhibitors.
    Fraley ME; Hoffman WF; Arrington KL; Hungate RW; Hartman GD; McFall RC; Coll KE; Rickert K; Thomas KA; McGaughey GB
    Curr Med Chem; 2004 Mar; 11(6):709-19. PubMed ID: 15032725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study.
    El-Sayed MA; El-Husseiny WM; Abdel-Aziz NI; El-Azab AS; Abuelizz HA; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):199-209. PubMed ID: 29251017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo.
    Ma J; Xin X; Meng L; Tong L; Lin L; Geng M; Ding J
    PLoS One; 2008; 3(11):e3774. PubMed ID: 19020661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and purification of the catalytic domain of human vascular endothelial growth factor receptor 2 for inhibitor screening.
    Zhong L; Guo XN; Zhang XH; Wu ZX; Luo XM; Jiang HL; Lin LP; Zhang XW; Ding J
    Biochim Biophys Acta; 2005 Apr; 1722(3):254-61. PubMed ID: 15715968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment of the active catalytic domain of human PDGFRbeta tyrosine kinase-based ELISA assay for inhibitor screening.
    Zhang XH; Guo XN; Zhong L; Luo XM; Jiang HL; Lin LP; Ding J
    Biochim Biophys Acta; 2007 Oct; 1770(10):1490-7. PubMed ID: 17719179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.